Monitoring of neoadjuvant radiation therapy by positron emission tomography in oral squamous cell carcinoma;Therapiemonitoring mittels 2-[18F]-FDG-positronenemissionstomographie nach neoadjuvanter strahlenbehandlung des mundhöhlenkarzinoms

Strahlentherapie und Onkologie

Volumn 177, Issue 3, 2001, Pages 145-152

  Kunkel, Martin ^a   Grötz, Knut A ^a   Förster, Gregor J ^a   Wahlmann, Ulrich ^a   Benz, Peter ^a   Kutzner, Joachim ^a   Rippin, Gerd ^a   Wagner, Wilfried ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

PET; Radiation monitoring; Radiation ontology; ROC analysis; Squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; GLUCOSE TRANSPORT; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MINIMAL RESIDUAL DISEASE; MONITORING; MOUTH CARCINOMA; POSITRON EMISSION TOMOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS CELL CARCINOMA; TUMOR REGRESSION; ADJUVANT THERAPY; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MOUTH TUMOR; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0034745452     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00002395     Document Type: Article

References (28)

1. Detection of unsuspected recurrent lymphoma with fluorodeoxyglucose-positronen emission tomographic imaging after induction chemotherapy. A case study
2. Definitionen zum radikalchirurgischen vorgehen bei plattenepithelkarzinomen der mundhöhle
3. Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy
4. Die positronenemissionstomographie (PET) bei der diagnostik und therapiekontrolle von malignen lymphomen
5. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation
6. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy
7. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy
8. PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine
9. Prognostische überlegungen zum mundhöhlenkarzinom auf der grundlage des DÖSAK-tumorregisters
10. 18F-fluordeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging
11. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET
12. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms
13. Improved survival with preoperative chemotherapy followed by resection uncompromised by tumor response for advanced squamous cell carcinoma of the head and neck
14. Current role of positron emission tomography in thoracic oncology
15. PET scanning in head and neck oncology: A review
16. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose
17. Präoperative radio-chemotherapie und radikale operation fortgeschrittener mundhöhlenkarzinome - Abschlussergebnisse einer prospektiven therapiestudie des DÖSAK
18. Der heutige stellenwert adjuvanter verfahren im behandlungskonzept des plattenepithelkarzinoms der mundhöhle und/oder des oropharynx
19. Diagnostik maligner Kopf-Hals-Tumoren durch F-18-FDG PET im Vergleich zu CT/MRT
20. Stellenwert der 18-F-fluordeoxyglucose-positronenemissionstomographie in der radiotherapieplanung von Kopf-Hals-Tumoren
21. Konsensus-Onko-PET
22. Chemotherapeutic management of head and neck malignancies with positron emission tomography
23. Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose
24. Intensified regimen for advanced head and neck squamous cell carcinomas
25. The application of PET in clinical oncology
26. Preoperative cisplatin and accelerated hyperfractioned radiation induce high tumor response and control rates in patients with advanced head and neck cancer
27. Relevance of positron emission tomography (PET) in oncology